DR. MICHAEL DAVID LONG M.D. NPI 1386676542

NPI Details

DR. Michael David Long, M.D. is a dermatology in Lubbock, TX with 33 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. DR. Michael David Long, M.D. NPI is 1386676542. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TEXAS TECH UNIVERSITY HEALTH SCIENCE CENTER SCHOOL OF MEDICINE
Graduation Year:1993

The provider's business location address is:

6012 82ND ST STE 15
LUBBOCK, TX
ZIP 79424-671
Phone: (806) 749-7933
Fax: (806) 749-6117

The NPI 1386676542 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks (HCPCS:17311)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks (HCPCS:17312)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm (HCPCS:12052)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Removal and microscopic exam of growth, each additional block after 5 tissue blocks (HCPCS:17315)
• Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less (HCPCS:15260)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm (HCPCS:12053)
• Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less (HCPCS:14060)
• Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm (HCPCS:12042)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 7/7/2006 and was last updated on 5/17/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.